At a glance
ClinicalIndex Comparison RecordN/ACompleted· 122 enrolled
Drug / intervention
Vivaer Stylusdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective, Multicenter Study of the AERin Medical Vivaer® ARC Stylus for Nasal AirWAY Obstruction (AERWAY)
In Brief
A clinical study evaluating Vivaer Stylus for Nasal Obstruction. Completed, enrolled 122 participants across 10 sites.
Detailed Summary
Post-market study to continue to evaluate the effectiveness of the Vivaer® ARC Stylus for nasal airway obstruction
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNasal Obstruction
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
Enrollment StartFeb 2020
First PostedFeb 2020
Primary CompletionDec 2020
Study CompletionOct 2024
TodayJul 2026
First PostedFeb 20, 2020
Enrollment StartFeb 7, 2020
Primary CompletionDec 31, 2020
Study CompletionOct 11, 2024
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 6.4 years ago
Interventions
Vivaer Stylusdevice
Delivery of low-power, temperature-controlled, radiofrequency energy to the tissues of the internal nasal valve area